Dexrazoxane should be used cautiously in patients with pre-existing bone marrow suppression, as it may exacerbate hematologic toxicity. Patients with renal impairment may require dose adjustments due to the drug's renal excretion. It is also important to monitor cardiac function and blood cell counts regularly during treatment.
